Levodropropizine

Specifications

99291-25-5CAS Number

640-087-8EC Number

(2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diolIUPAC Name

C13H20N2O2Chemical Formula

236.31 g/molMolecular Weight

Levodropropizine; 99291-25-5; Levotuss; Danka; (-)-Dropropizine; Levdropropizine; (S)-(-)-Dropropizine; Rapitux; Levodropropizina; Levodropropizinum; Levopront; L-dropropizine; Dropropizine, (s)-; 3O31P6T4G3; (-)-(S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol; DTXSID8023210; CHEBI:82722; Levdropropizina; dipropizine, (S)-; RefChem:153202; DTXCID003210; R05DB27; (S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; (2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol; MFCD00866852; Levodropropizine [INN]; dipropizine, (S)-isomer; (s)-3-(4-phenyl-1-piperazinyl)-1,2-propanediol; 1,2-Propanediol, 3-(4-phenyl-1-piperazinyl)-, (2S)-; Levodropropizine (INN); Dropropizine S-form; Levodropropizinum [INN-Latin]; Levodropropizina [INN-Spanish]; DF 526; Levodropropizine [INN:BAN]; Salvituss; UNII-3O31P6T4G3; Levopront (TN); CAS-17692-31-8; Levodropropizine CRS; S(-)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; LVDP; Levodropropizine (Standard); SCHEMBL29043; orb1223469; orb1310823; CHEMBL1288810; LEVODROPROPIZINE [MART.]; HY-B1895R; (2S)-3-(4-PHENYL-1-PIPERAZINYL)-1,2-PROPANEDIOL; 1,2-Propanediol, 3-(4-phenylpiperazin-1-yl)-, S(-)-; DROPROPIZINE S-FORM [MI]; LEVODROPROPIZINE [WHO-DD]; HMS3885B07; HY-B1895; BBL036696; EBC-03709; s4131; STL559075; AKOS015889397; AC-2084; AC-8088; CCG-266840; CS-5212; DB12472; FP31559; LEVODROPROPIZINE [EP MONOGRAPH]; NCGC00016730-01; NCGC00016730-13; NCGC00018230-01; NCGC00018230-06; AS-12822; SY237559; L0339; NS00096429; D08119; F15098; EN300-1718684; AO-022/43512153; F211612; Q408131; BRD-K83551379-001-01-8; BRD-K83551379-001-02-6; S-(-)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; Z301111588; 1,2-PROPANEDIOL, 3-(4-PHENYL-1-PIPERAZINYL)-, (S)-Synonyms